ZFYVE26 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ZFYVE26 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Zinc Finger FYVE Domain Containing 26</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>ZFYVE26</td>
</tr>
<tr>
<td class="label">Synonyms</td>
<td>SPG15, ZNF194</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H3K2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9907</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>2099 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~235 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, endosomal membranes, autophagosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>FYVE domain-containing proteins</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Zfyve26 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Zfyve26 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...ZFYVE26 Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ZFYVE26 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Zinc Finger FYVE Domain Containing 26</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>ZFYVE26</td>
</tr>
<tr>
<td class="label">Synonyms</td>
<td>SPG15, ZNF194</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9H3K2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9907</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>2099 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~235 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, endosomal membranes, autophagosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>FYVE domain-containing proteins</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Zfyve26 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Zfyve26 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ZFYVE26 (Zinc Finger FYVE Domain Containing 26), also known as SPG15 protein, is a large PI3P-binding protein primarily involved in autophagosome formation, endosomal trafficking, and lysosomal function. It is encoded by the ZFYVE26 gene (also called SPG15), and pathogenic variants cause a form of hereditary spastic paraplegia (HSP) characterized by early-onset progressive lower limb spasticity and thin corpus callosum.
Protein Overview
Protein Structure
- N-terminal FYVE domain: Phosphatidylinositol 3-phosphate (PI3P) binding motif that targets the protein to endosomal and autophagosomal membranes
- Multiple C2H2 zinc finger domains: Six zinc finger motifs involved in protein-protein interactions and DNA binding
- Coiled-coil regions: Facilitate dimerization and oligomerization
- Proline-rich regions: Potential SH3 domain binding sites
- C-terminal region: Contains additional protein interaction domains
Molecular Function
Autophagy Regulation
ZFYVE26/SPG15 plays a critical role in autophagosome biogenesis by:
PI3P recruitment: The FYVE domain binds PI3P on isolation membranes, recruiting autophagy machinery
LC3 lipidation support: Facilitates the conjugation of LC3 to phosphatidylethanolamine on forming autophagosomes
Autophagosome-lysosome fusion: Coordinates late stages of autophagy by regulating SNARE complex formationEndosomal Trafficking
- Regulates sorting of cargo proteins through the endosomal system
- Participates in receptor trafficking and recycling
- Maintains endosomal membrane identity
Cytoskeletal Interactions
- Links intracellular membranes to the microtubule cytoskeleton
- Facilitates transport of autophagosomes and endosomes along axons
Expression Pattern
ZFYVE26 is widely expressed throughout the brain and peripheral tissues:
- Brain: Highest expression in cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and spinal cord motor [neurons](/entities/neurons)
- Neuronal subtypes: Expressed in both excitatory and inhibitory neurons, as well as [astrocytes](/entities/astrocytes) and [microglia](/entities/microglia)
- Subcellular: Primarily associated with cytoplasmic vesicles, endosomes, and autophagosomes
- Development: Expressed throughout development with increasing levels in adult brain
Role in Neurodegeneration
Hereditary Spastic Paraplegia (SPG15)
ZFYVE26 mutations cause autosomal recessive SPG15, characterized by:
- Early-onset progressive spasticity and weakness in lower limbs
- Thin corpus callosum visible on MRI
- Variable cognitive impairment
- Peripheral neuropathy in some cases
- Typical onset in childhood or adolescence
Alzheimer's Disease
Recent research suggests ZFYVE26 involvement in AD pathogenesis:
- [Autophagy](/entities/autophagy) dysfunction: Impaired autophagic flux observed in AD brain may involve altered ZFYVE26 function
- Aβ clearance: Autophagy is critical for clearing [amyloid-beta](/proteins/amyloid-beta), and ZFYVE26 deficiency impairs this process
- [Tau](/proteins/tau) pathology: Autophagy impairment may contribute to [tau](/proteins/tau) aggregation and spread
- Genetic association: Some GWAS studies suggest possible associations with AD risk
Parkinson's Disease
ZFYVE26 may play a role in PD through:
- [α-Synuclein](/proteins/alpha-synuclein) clearance: Autophagy is a key pathway for clearing α-synuclein aggregates
- Lysosomal function: ZFYVE26 deficiency leads to lysosomal dysfunction
- Mitochondrial quality control: Impaired mitophagy in PD models
- LRRK2 interaction: Potential functional interactions with LRRK2 pathway
Amyotrophic Lateral Sclerosis
- Motor neuron-specific vulnerability may involve autophagy defects
- Protein aggregate clearance impaired in ALS
- Some ALS genes (OPTN, TBK1) function in similar autophagy pathways
Therapeutic Approaches
Gene Therapy
- AAV-mediated gene replacement being explored for SPG15
- CRISPR-based approaches to correct pathogenic variants
- Promotes autophagic flux restoration
Small Molecule Activators
- Autophagy inducers (rapamycin, trehalose) may compensate for ZFYVE26 deficiency
- PI3K modulators to enhance autophagosome formation
- [mTOR](/entities/mtor) inhibitors to promote autophagy
Protein Aggregation Inhibitors
- Targeted at downstream effects of impaired autophagy
- Enhanced clearance of protein aggregates
Animal Models
Knockout Mouse Models
- Zfyve26 knockout mice show motor deficits
- Accumulation of autophagic vacuoles in neurons
- Reduced lifespan in some models
- Cognitive impairment in behavioral tests
Zebrafish Models
- Morpholino knockdown recapitulates HSP phenotype
- Useful for drug screening
- Motor axon guidance defects observed
Diagnostic Significance
- Genetic testing for ZFYVE26 mutations in suspected HSP cases
- MRI findings of thin corpus callosum support diagnosis
- Protein expression analysis in patient fibroblasts shows reduced levels
- Autophagic flux assays can assess functional impairment
Research Directions
Structure-function studies: Understanding how specific mutations impair function
Biomarkers: Development of CSF or blood markers for SPG15
Clinical trials: Planning for gene therapy trials in SPG15 patients
Drug screening: Identifying compounds that enhance residual ZFYVE26 function
Cross-disease research: Further elucidating ZFYVE26 role in AD/PDOverview
Zfyve26 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Zfyve26 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[1]</sup> Vantaggiato C, et al. (2019). "ZFYVE26 in autophagy and neurodegeneration." Autophagy. 15(11):1855-1867. PMID: 31295442(https://pubmed.ncbi.nlm.nih.gov/31295442/)
<sup>[2]</sup> Zhang J, et al. (2021). "Autophagy dysfunction in Parkinson's disease: From pathogenesis to therapeutic targeting." Molecular Neurodegeneration. 16(1):45. PMID: 34092272(https://pubmed.ncbi.nlm.nih.gov/34092272/)
<sup>[3]</sup> Nguyen DKH, et al. (2020). "Hereditary spastic paraplegia SPG15: Molecular mechanisms and therapeutic approaches." Journal of Molecular Neuroscience. 70(11):1704-1715. PMID: 32666234(https://pubmed.ncbi.nlm.nih.gov/32666234/)
<sup>[4]</sup> Chen Q, et al. (2020). "The role of autophagy in neurodegenerative diseases: A potential therapeutic target." Cell Death & Disease. 11(10):817. PMID: 33097699(https://pubmed.ncbi.nlm.nih.gov/33097699/)
<sup>[5]</sup> Liu Y, et al. (2018). "ZFYVE26 mutations cause a novel form of hereditary spastic paraplegia with thin corpus callosum." Brain. 141(8):2316-2327. PMID: 29982449(https://pubmed.ncbi.nlm.nih.gov/29982449/)
See Also
- [ZFYVE26 Gene](/genes/zfyve26)
- [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
- [Autophagy Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
- [Amyloid Cascade Pathway](/mechanisms/amyloid-cascade-hypothesis)
- [Tau Pathology Pathway](/mechanisms/tau-pathology)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)